NCT01648023View on ClinicalTrials.gov

Drug-Eluting Bead, Irinotecan Therapy for Unresectable Intrahepatic Cholangiocarcinoma w/Concomitant Gemcitabine and Cisplatin or Carboplatin

PHASE2CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

January 31, 2019

Study Completion Date

September 30, 2019

Conditions
Unresectable Intrahepatic Cholangiocarcinoma
Interventions
DEVICE

LC or ONCOZENE Bead with Gem-Cis or Gem-Carbo

DRUG

Gem-Cis or Gem-Carbo

Trial Locations (1)

40202

University of Louisville, Louisville

All Listed Sponsors
lead

Robert C. Martin

OTHER

NCT01648023 - Drug-Eluting Bead, Irinotecan Therapy for Unresectable Intrahepatic Cholangiocarcinoma w/Concomitant Gemcitabine and Cisplatin or Carboplatin | Biotech Hunter | Biotech Hunter